logo

MYNZ

Mainz Biomed·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --

MYNZ fundamentals

Mainz Biomed (MYNZ) expects to report earnings on Aug 9, 2024, with estimated revenue of 200.00K (YoY -20.03%), and EPS at -0.21 (YoY +53.33%).
Revenue estimate / YoY
200.00K
-20.03%
EPS estimate / YoY
-0.21
+53.33%
Report date
Aug 9, 2024
EPS
Revenue

Revenue & Expenses

MYNZ has released its 2023 Q4 earnings report, with revenue of 214.76K, reflecting a YoY change of 11.11%, and net profit of -5.18M, showing a YoY change of 36.70%. The Sankey diagram below clearly presents MYNZ's revenue sources and cost distribution.

Key Indicators

Mainz Biomed (MYNZ) key financial stats and ratios, covering profitability, financial health, and leverage.
Mainz Biomed (MYNZ)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Mainz Biomed (MYNZ)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Mainz Biomed (MYNZ)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Mainz Biomed (MYNZ) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Mainz Biomed (MYNZ) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield